Page 4 - Present Status News Today

A Pioneer Solar Power Plant

Manipur Chief Minister N Biren Singh informed that around 40 thousand people are being employed under the Van Dhan Vikas Karyakram of TRIFED.

The speakers at the event said people’s participation is one of the key issues in implementing the Sustainable Development Goals

— Follows important findings from the TATTON1 study of the combination in EGFR inhibitor refractory lung cancer patients whose tumors harbor aberrations of...

  Professor Panduka Karunanayake of the Faculty of Medicine, Colombo has issued a very welcome book: mostly a collection of essays and notes he wrote to newspapers and two public lectures. They cover huge areas of social policy and therefore are very likely to give rise to public debate, all very welcome. Panduka (if he will pardon me) belongs in a tradition of medical personnel who have interested themselves in problems in this society, well beyond health and medical care. Gunadasa Amaraseker...

The Over-the-Top Library With a Secret Treasure William O’Connor © Provided by The Daily Beast Alamy It would be understandable if, after taking in the ornate reading rooms and grand hallways of the St. Louis Central Library, you deemed your thirst for literary splendor sated. However, tucked into one of those walls is an elegant but easily missed double door underneath a broken pediment leading to a true treasure trove filled with items that would fetch eye-popping sums at...

  of patients with early-stage EGFR-mutated lung cancer   Tagrisso is the only targeted medicine to show efficacy in the treatment of early-stage lung cancer in a global trial and the first such medicine approved in China   where Tagrisso reduced the risk of disease recurrence or death by 80%   AstraZenecas Tagrisso (osimertinib) has been approved in China for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growt...

  In the ADAURA Phase III trial, chemotherapy use was balanced across the two treatment arms, with 60% of patients receiving prior adjuvant chemotherapy. In line with uptake observed in prior studies and clinical practice, younger patients (

TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative intent. TAGRISS...

ADDING MULTIMEDIA TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curati...